Notably, treatment with an IFN-g neutralizing Ab suppressed CD4+ cell, presumably CD4+ T cells, infiltration into tumors treated with the anti-CTLA-4 Ab, providing evidence that IFN-g produced from tumor-infiltrating Th1 can accelerate the infiltration of CD4+ T cells. The gene discussed is CTLA4; the disease is neoplasm.